60 likes | 155 Views
The Challenge: Tendering for Unlicensed medicines Oct 30 th 2012. Tim Root Specialist Pharmacist Clinical Governance & Technical Services. The context. NHS re-disorganisation Cost pressures +++ More, more complex medicines vs less nursing time Regulatory & legal pressures
E N D
The Challenge: Tendering for Unlicensed medicinesOct 30th 2012 Tim Root Specialist Pharmacist Clinical Governance & Technical Services
The context NHS re-disorganisation Cost pressures +++ More, more complex medicines vs less nursing time Regulatory & legal pressures NHS preparative capacity stressed & at risk(?) Demand increasing Competition increasing
Issues Licensed medicines carry a guarantee of Q,S,E Nothing can be assumed about QSE of unlicensed medicines We have tried & tested systems & processes for tendering to buy medicines They were developed for (products) licensed medicines Prices of licensed medicines are regulated Prices of unlicensed medicines aren’t Service is a critical
Experience Overlabelled & repacked medicines Dose banded cytotoxics CIVAS Other UMPs Product specification Mixed blessings Procurement and clinical and QA expertise essential at all stages
Summary Quality & Safety is our responsibility always comes first Licensed medicines are the gold standard should always be the ultimate objective but….. regulatory compliance isn’t the same as fitness for purpose We must develop coherent strategy Do once and share Including market management to secure essential NHS services Tendering is here to stay: we can make it work for everyone’s benefit!